Hiley C R, Douglas S A, Randall M D
Department of Pharmacology, University of Cambridge, England.
J Cardiovasc Pharmacol. 1989;13 Suppl 5:S197-9. doi: 10.1097/00005344-198900135-00055.
Human/porcine endothelin-1 (ET-1) dose-dependently increased perfusion pressure in both Krebs-Henseleit and blood-perfused superior mesenteric arterial bed preparations of the rat. In vitro, it was a partial agonist relative to two analogs, [Ala1,15]- and [Ala3,11]-ET-1, and the maximum response was increased by removal of the endothelium. Endothelial destruction had no effect on the responses to either [Ala1,15]- or [Ala3,11]-ET-1. [Ala1,3,11,15]-ET-1 was not an agonist in vitro but was a partial agonist relative to ET-1 and [Ala1,15]- and [Ala3,11]-ET-1 in vivo. Also, the responses to [Ala1,15]-ET-1 in the blood-perfused preparation were best described by a two-site model. These results suggest that there may be two types of receptor for these peptides. In vivo, 5 mg/kg of indomethacin potentiated the maximum response to ET-1, suggesting that its actions may be opposed by vasodilator cyclo-oxygenase products.
人/猪内皮素-1(ET-1)可使大鼠的克氏-亨氏液灌注及血液灌注的肠系膜上动脉床标本的灌注压呈剂量依赖性升高。在体外,相对于两种类似物[Ala1,15]-ET-1和[Ala3,11]-ET-1,它是一种部分激动剂,去除内皮可增强最大反应。内皮破坏对[Ala1,15]-ET-1或[Ala3,11]-ET-1的反应无影响。[Ala1,3,11,15]-ET-1在体外不是激动剂,但在体内相对于ET-1、[Ala1,15]-ET-1和[Ala3,11]-ET-1是一种部分激动剂。此外,血液灌注标本对[Ala1,15]-ET-1的反应可用双位点模型进行最佳描述。这些结果提示这些肽可能存在两种类型的受体。在体内,5mg/kg的吲哚美辛可增强对ET-1的最大反应,提示其作用可能受到血管舒张性环氧化酶产物的拮抗。